Stock Events

Stock Events

Nemaura Medical 

$0.000100
9
+$0.00+0% Tuesday 20:00

Statistics

Day High
0.0002
Day Low
0.0002
52W High
0.0005
52W Low
0.00001
Volume
500
Avg. Volume
1,076
Mkt Cap
2,889.9
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

22NovExpected
Q4 2022
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-0.18
-0.14
-0.09
-0.05
Expected EPS
-0.11
Actual EPS
N/A

Financials

-18,368.83%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
77,000Revenue
-14.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NMRD. It's not an investment recommendation.
Apple
3
AAPL
Realty Income
3
O
Tesla
3
TSLA
Amazon
3
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Dexcom
DXCM
Mkt Cap34.27B
DexCom, Inc. specializes in continuous glucose monitoring (CGM) systems, directly competing with Nemaura Medical's non-invasive glucose monitoring technology.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers the FreeStyle Libre, a CGM system that competes with Nemaura's glucose monitoring solutions.
Tandem Diabetes Care
TNDM
Mkt Cap1.49B
Tandem Diabetes Care, Inc. manufactures and sells insulin pumps and other diabetes management devices, competing in the broader diabetes care market.
Insulet
PODD
Mkt Cap10.07B
Insulet Corporation produces the Omnipod, an insulin management system, competing in the insulin delivery market alongside Nemaura's diabetes management solutions.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc offers a range of diabetes management products, including CGM systems and insulin pumps, competing with Nemaura's technologies.
Senseonics
SENS
Mkt Cap493.31M
Senseonics Holdings, Inc. develops and manufactures the Eversense CGM system, a direct competitor to Nemaura's glucose monitoring products.
Mannkind
MNKD
Mkt Cap1.27B
MannKind Corporation focuses on inhaled insulin products, offering alternative diabetes management solutions that compete with Nemaura's offerings.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc., while primarily focused on orthopedics, has ventured into diabetes care, potentially competing with Nemaura Medical in the future.

About

Nemaura Medical Inc. is a medical technology company dedicated to inventing, developing, and bringing to market diagnostic medical devices. Its flagship product, sugarBEAT, is an innovative, non-invasive continuous glucose monitoring (CGM) system. This device is designed to assist individuals with Type 1 and Type 2 diabetes in managing their condition, and it can also screen for pre-diabetic states. Beyond this, Nemaura offers proBEAT, a wellness guidance service that delivers educational prompts to users about factors influencing their blood sugar profiles. The company also conducts specialized programs aimed at diabetes prevention and reversal. Established in 2009, Nemaura Medical Inc. operates from its headquarters in New York City.
Show more...
CEO
Dewan Fazlul Hoque Chowdhury
Employees
38
Country
United States
ISIN
US6404422080
WKN
000A2PWNG

Listings

OTC Link
US
NMRD

0 Comments

Share your thoughts

FAQ

What is Nemaura Medical stock price today?▼
The current price of NMRD is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Nemaura Medical stock price performance more closely on the chart.
What is Nemaura Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Nemaura Medical stocks are traded under the ticker NMRD.
Is Nemaura Medical stock price growing?▼
NMRD stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Nemaura Medical has showed a +0% increase.
What is Nemaura Medical market cap?▼
Today Nemaura Medical has the market capitalization of 2,889.9
What is Nemaura Medical revenue for the last year?▼
Nemaura Medical revenue for the last year amounts to 77,000 USD.
What is Nemaura Medical net income for the last year?▼
NMRD net income for the last year is -14.14M USD.
How many employees does Nemaura Medical have?▼
As of September 04, 2026, the company has 38 employees.
In which sector is Nemaura Medical located?▼
Nemaura Medical operates in the Health & Wellness sector.
When did Nemaura Medical complete a stock split?▼
The last stock split for Nemaura Medical was on December 05, 2019 with a ratio of 1:10.
Where is Nemaura Medical headquartered?▼
Nemaura Medical is headquartered in New York City, United States.